Review ArticlePractice
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia
Evidence-based clinical practice guideline
Lise M. Bjerre, Barbara Farrell, Matthew Hogel, Lyla Graham, Geneviève Lemay, Lisa McCarthy, Lalitha Raman-Wilms, Carlos Rojas-Fernandez, Samir Sinha, Wade Thompson, Vivian Welch and Andrew Wiens
Canadian Family Physician January 2018, 64 (1) 17-27;
Lise M. Bjerre
Assistant Professor in the Department of Family Medicine and in the School of Epidemiology and Public Health at the University of Ottawa in Ontario, Scientist in the C.T. Lamont Primary Health Care Research Centre of the Bruyère Research Institute, and Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES).
MD PhD CCFPBarbara Farrell
Assistant Professor in the Department of Family Medicine at the University of Ottawa, Adjunct Assistant Professor in the School of Pharmacy at the University of Waterloo in Ontario, and Scientist at the Bruyère Research Institute at the University of Ottawa.
PharmD ACPR FCSHPMatthew Hogel
Research Associate at the Bruyère Research Institute at the time of guideline development.
PhDLyla Graham
Medical Director of St Patrick’s Home of Ottawa and Assistant Professor in the Department of Family Medicine at the University of Ottawa.
MDGeneviève Lemay
Assistant Professor of Medicine at the University of Ottawa, Chief of Geriatric Services at Hôpital Montfort, and a staff geriatrician with the Ottawa Hospital Division of Geriatrics.
MD MSc FRCPCLisa McCarthy
Scientist at the Women’s College Research Institute of Women’s College Hospital in Toronto, Ont, and Assistant Professor with the Leslie Dan Faculty of Pharmacy and the Department of Family and Community Medicine at the University of Toronto.
PharmD MScLalitha Raman-Wilms
Associate Professor and Associate Dean of Professional Programs in the Leslie Dan Faculty of Pharmacy at the University of Toronto at the time of guideline development.
PharmD FCSHPCarlos Rojas-Fernandez
Schlegel Research Chair in Geriatric Pharmacotherapy at the Schlegel-UW Research Institute on Ageing and the School of Pharmacy at the University of Waterloo at the time of guideline development.
PharmDSamir Sinha
Director of Geriatrics at Mount Sinai Hospital and the University Health Network hospitals in Toronto, Assistant Professor in the Department of Medicine, the Department of Family and Community Medicine, and the Institute for Health Policy, Management and Evaluation at the University of Toronto, and Assistant Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine in Baltimore, MD.
MD DPhil FRCPCWade Thompson
Master’s student in the School of Epidemiology and Public Health at the University of Ottawa at the time of guideline development.
RPh MScVivian Welch
Director of the Methods Centre at the Bruyère Research Institute and Assistant Professor in the School of Epidemiology and Public Health at the University of Ottawa at the time of guideline development.
PhDAndrew Wiens
Associate Professor and Head of the Division of Geriatric Psychiatry in the Department of Psychiatry at the University of Ottawa.
MDData supplements
CFPlus Additional Information
CFPlus Additional Information
CFPlus Additional Information
This data supplement contains Figure 1 and an Appendix from the clinical practice guidelines for deprescribing antipsychotics.
Files in this Data Supplement:
In this issue
Canadian Family Physician
Vol. 64, Issue 1
1 Jan 2018
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia
Lise M. Bjerre, Barbara Farrell, Matthew Hogel, Lyla Graham, Geneviève Lemay, Lisa McCarthy, Lalitha Raman-Wilms, Carlos Rojas-Fernandez, Samir Sinha, Wade Thompson, Vivian Welch, Andrew Wiens
Canadian Family Physician Jan 2018, 64 (1) 17-27;
Respond to this article
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia
Lise M. Bjerre, Barbara Farrell, Matthew Hogel, Lyla Graham, Geneviève Lemay, Lisa McCarthy, Lalitha Raman-Wilms, Carlos Rojas-Fernandez, Samir Sinha, Wade Thompson, Vivian Welch, Andrew Wiens
Canadian Family Physician Jan 2018, 64 (1) 17-27;
Jump to section
Related Articles
Cited By...
- Dix annees de travaux lies aux guides de pratique clinique sur la deprescription: Ou en sommes-nous maintenant?
- Ten years of deprescribing guideline work: Where are we now?
- Managing neuropsychiatric symptoms in patients with dementia
- Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings
- Effect of a multimethod quality improvement intervention on antipsychotic medication use among residents of long-term care
- Exploration of home care nurses experiences in deprescribing of medications: a qualitative descriptive study
- Problem-based deprescribing: Using your patients clinical concerns to guide medication review
- Public reporting of antipsychotic prescribing in nursing homes: population-based interrupted time series analyses
- Antipsychotics for agitation in dementia
- The hidden curriculum and continuing professional development for family physicians
- Les antipsychotiques pour lagitation dans les cas de demence
- Deprescribing: When trying for less is more